ENZY.ST
Enzymatica AB (publ)
Price:  
3.10 
SEK
Volume:  
54,876.00
Sweden | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ENZY.ST EV/EBITDA

-139.6%
Upside

As of 2025-05-18, the EV/EBITDA ratio of Enzymatica AB (publ) (ENZY.ST) is -13.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ENZY.ST's latest enterprise value is 687.76 mil SEK. ENZY.ST's TTM EBITDA according to its financial statements is -51.64 mil SEK. Dividing these 2 quantities gives us the above ENZY.ST EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 4.2x - 13.0x 7.3x
Forward P/E multiples 5.2x - 8.2x 6.8x
Fair Price (0.84) - (1.49) (1.23)
Upside -127.2% - -147.9% -139.6%
3.10 SEK
Stock Price
(1.23) SEK
Fair Price

ENZY.ST EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-05-16 -13.32
2025-05-15 -13.88
2025-05-14 -14.45
2025-05-13 -15.11
2025-05-12 -13.60
2025-05-09 -12.71
2025-05-08 -12.80
2025-05-07 -13.18
2025-05-06 -12.85
2025-05-05 -12.85
2025-05-02 -13.32
2025-04-30 -12.47
2025-04-29 -13.41
2025-04-28 -14.49
2025-04-25 -15.20
2025-04-24 -14.64
2025-04-23 -14.54
2025-04-22 -14.64
2025-04-17 -14.87
2025-04-16 -14.96
2025-04-15 -14.02
2025-04-14 -14.73
2025-04-11 -14.73
2025-04-10 -13.55
2025-04-09 -14.59
2025-04-08 -16.00
2025-04-07 -15.48
2025-04-04 -15.48
2025-04-03 -17.55
2025-04-02 -17.83
2025-04-01 -18.91
2025-03-31 -19.52
2025-03-28 -18.11
2025-03-27 -18.96
2025-03-26 -20.65
2025-03-25 -21.03
2025-03-24 -20.65
2025-03-21 -21.50
2025-03-20 -19.90
2025-03-19 -21.31
2025-03-18 -21.78
2025-03-17 -18.40
2025-03-14 -16.05
2025-03-13 -12.85
2025-03-12 -13.22
2025-03-11 -14.92
2025-03-10 -14.73
2025-03-07 -14.45
2025-03-06 -14.17
2025-03-05 -14.07